These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12219723)

  • 1. A review of the applications of imiquimod: a novel immune response modifier.
    Syed TA
    Expert Opin Pharmacother; 2001 May; 2(5):877-82. PubMed ID: 12219723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory and pharmacologic properties of imiquimod.
    Sauder DN
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S6-11. PubMed ID: 10861101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod applied topically: a novel immune response modifier and new class of drug.
    Miller RL; Gerster JF; Owens ML; Slade HB; Tomai MA
    Int J Immunopharmacol; 1999 Jan; 21(1):1-14. PubMed ID: 10411278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod and resiquimod as novel immunomodulators.
    Dockrell DH; Kinghorn GR
    J Antimicrob Chemother; 2001 Dec; 48(6):751-5. PubMed ID: 11733457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
    Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical imiquimod: mechanism of action and clinical applications.
    Vidal D
    Mini Rev Med Chem; 2006 May; 6(5):499-503. PubMed ID: 16719822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action and other potential roles of an immune response modifier.
    Gaspari AA
    Cutis; 2007 Apr; 79(4 Suppl):36-45. PubMed ID: 17508494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience in treating molluscum contagiosum in children with imiquimod 5% cream.
    Bayerl C; Feller G; Goerdt S
    Br J Dermatol; 2003 Nov; 149 Suppl 66():25-9. PubMed ID: 14616342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dermatologic uses of the immune response modifier imiquimod 5% cream.
    Berman B; Poochareon VN; Villa AM
    Skin Therapy Lett; 2002 Nov; 7(9):1-6. PubMed ID: 12548325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imiquimod 5% cream use in dermatology, side effects and recent patents.
    Cantisani C; Lazic T; Richetta AG; Clerico R; Mattozzi C; Calvieri S
    Recent Pat Inflamm Allergy Drug Discov; 2012 Jan; 6(1):65-9. PubMed ID: 22185454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response modification: imiquimod.
    Tyring S
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S11-3. PubMed ID: 9842095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod.
    Garland SM
    Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod; an international update on therapeutic uses in dermatology.
    Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
    Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.
    Stanley MA
    Clin Exp Dermatol; 2002 Oct; 27(7):571-7. PubMed ID: 12464152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod applied topically: A novel immune response modifier.
    Tyring S
    Skin Therapy Lett; 2001 Mar; 6(6):1-4. PubMed ID: 11298484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod in dermatology: an overview.
    Hanna E; Abadi R; Abbas O
    Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.